Planned sales, announced before they happen
6 trading plans running, 23 Form 144 notices for $158.3M
Plans running now
6
Janet Napolitano, Christiane Ohlgart, John Whittle, Michael Xie, Ken Xie
What FTNT's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Trading plans
Plans adopted or ended
| Insider | What | Date | Shares | Runs to | Reported in |
|---|---|---|---|---|---|
| Janet Napolitano | Adopted 10b5-1 plan | Aug 31, 2026 | up to 390 | Dec 3, 2027 | 10-Q Oct 30, 2026 |
What the company wroteOn August 31, 2026, Janet Napolitano, one of our directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Napolitano Plan”) during an open trading window in accordance with our insider trading policy. The Napolitano Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Napolitano Plan provides for the potential sale by Ms. Napolitano of up to 390 shares of our common stock, plus up to 60% of the additional net shares (the number of which is not yet determinable) remaining after shares are withheld to satisfy tax obligations upon vesting and settlement of RSUs, in each case, at prices determined in accordance with the terms of the Napolitano Plan, all between November 30, 2026 and December 3, 2027. The Napolitano Plan includes a representation from Ms. Napolitano to the broker administering the plan that she was not in possession of any material nonpublic information regarding us or the securities subject to the Napolitano Plan at the time that she entered into the Napolitano Plan. She made a similar representation to us in connection with the adoption of the Napolitano Plan under our insider trading policy. The representation was made as of August 31, 2026, and speaks only as of that date. In making the representation, Ms. Napolitano did not provide assurance with respect to any material nonpublic information of which she was unaware, or with respect to any material nonpublic information acquired by her or us after the date of the representation. Once executed, transactions under the Napolitano Plan will be disclosed publicly through Form 4 and/or Form 144 filings with the SEC in accordance with applicable securities laws, rules and regulations. Except as may be required by law, we do not undertake any obligation to update or report any modification, termination, or other activity under current or future Rule 10b5-1 plans that may be adopted by Ms. Napolitano or our other officers or directors, or their affiliated entities. | |||||
| Christiane Ohlgart Chief Financial Officer |
Adopted 10b5-1 plan | Jun 10, 2026 | up to 115 | Sep 15, 2027 | 10-Q Jul 30, 2026 |
What the company wroteOn June 10, 2026, Christiane Ohlgart, our Chief Financial Officer, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Ohlgart Plan”) during an open trading window in accordance with our insider trading policy. The Ohlgart Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Ohlgart Plan provides for the potential sale by Mrs. Ohlgart of up to 115 shares of our common stock, plus a number of additional net shares (which is not yet determinable) remaining after shares are withheld to satisfy tax obligations upon vesting and settlement of RSUs and PSUs, in each case, at prices determined in accordance with the terms of the Ohlgart Plan, all between September 9, 2026 and September 15, 2027. | |||||
| John Whittle Chief Operating Officer |
Adopted 10b5-1 plan | Jun 5, 2026 | up to 56,700 | Sep 30, 2027 | 10-Q Jul 30, 2026 |
What the company wroteOn June 5, 2026, John Whittle, our Chief Operating Officer, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Whittle Plan”) during an open trading window in accordance with our insider trading policy. The Whittle Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Whittle Plan provides for the potential sale by Mr. Whittle of up to 56,700 shares of our common stock, issued upon the exercise of vested stock options for shares of our common stock, at prices at or above a minimum price specified in the Whittle Plan, all between September 4, 2026 and September 30, 2027. | |||||
| Michael Xie Chief Technology Officer and one of our directors |
Adopted 10b5-1 plan | Mar 4, 2026 | up to 466,239 | Nov 30, 2027 | 10-Q May 8, 2026 |
What the company wroteOn March 4, 2026, Michael Xie, our Chief Technology Officer and one of our directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Michael Xie Plan”) during an open trading window in accordance with our insider trading policy. The Michael Xie Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Michael Xie Plan provides for the potential sale by Mr. Michael Xie of up to (a) 466,239 shares of our common stock, issued upon the vesting and settlement of RSUs for shares of our common stock and the exercise of vested options to purchase shares of our common stock and (b) the net shares (which are not yet determinable) after shares are withheld to satisfy tax obligations upon such vesting and settlement of RSUs and PSUs, in each case, at the market price, all between June 3, 2026 and November 30, 2027. | |||||
| Ken Xie Chief Executive Officer and one of our directors |
Adopted 10b5-1 plan | Mar 3, 2026 | up to 1,164,981 | Nov 30, 2027 | 10-Q May 8, 2026 |
What the company wroteOn March 3, 2026, Ken Xie, our Chief Executive Officer and one of our directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Ken Xie Plan”) during an open trading window in accordance with our insider trading policy. The Ken Xie Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Ken Xie Plan provides for the potential sale by Mr. Ken Xie of up to (a) 1,164,981 shares of our common stock, issued upon the vesting and settlement of RSUs for shares of our common stock and the exercise of vested options to purchase shares of our common stock and (b) the net shares (which are not yet determinable) after shares are withheld to satisfy tax obligations upon such vesting and settlement of RSUs and PSUs, in each case, at the market price, all between June 2, 2026 and November 30, 2027. | |||||
| John Whittle Chief Operating Officer |
Adopted 10b5-1 plan | Feb 19, 2026 | up to 146,015 | May 28, 2027 | 10-Q May 8, 2026 |
What the company wroteOn February 19, 2026, John Whittle, our Chief Operating Officer, modified an existing trading plan, which was originally adopted on March 3, 2025 in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Whittle Plan”) during an open trading window in accordance with our insider trading policy. The modified Whittle Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The modified Whittle Plan provides for the potential sale by Mr. Whittle of up to 146,015 shares of our common stock, issued upon the exercise of vested stock options for shares of our common stock, at the market price, between May 21, 2026 and May 28, 2027. | |||||
| Keith Jensen Chief Financial Officer |
Ended 10b5-1 plan | May 15, 2025 | not stated | – | 10-Q Aug 8, 2025 |
What the company wroteAs previously reported, our former Chief Financial Officer, Keith Jensen, retired on May 15, 2025. In connection with Mr. Jensen’s retirement, his pre-arranged written stock sale plan for the sale of shares of our common stock adopted on March 6, 2024 was terminated. | |||||
| Margrit Christiane Ohlgart Chief Accounting Officer |
Adopted 10b5-1 plan | Mar 7, 2025 | not stated | Sep 5, 2026 | 10-Q May 8, 2025 |
What the company wroteOn March 7, 2025, Margrit Christiane Ohlgart, our Chief Accounting Officer, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Ohlgart Plan”) during an open trading window in accordance with our insider trading policy. The Ohlgart Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Ohlgart Plan provides for the potential sale by Mrs. Ohlgart of net shares (which are not yet determinable) after shares are withheld to satisfy tax obligations upon vesting and settlement of RSUs and PSUs, in each case, at the market price, all between June 6, 2025 and September 5, 2026. | |||||
| John Whittle Chief Operating Officer |
Adopted 10b5-1 plan | Mar 3, 2025 | up to 146,015 | Jul 31, 2026 | 10-Q May 8, 2025 |
What the company wroteOn March 3, 2025, John Whittle, our Chief Operating Officer, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Whittle Plan”) during an open trading window in accordance with our insider trading policy. The Whittle Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Whittle Plan provides for the potential sale by Mr. Whittle of up to 146,015 shares of our common stock, issued upon the exercise of vested stock options for shares of our common stock, at the market price, between June 2, 2025 and July 31, 2026. | |||||
| Michael Xie Chief Technology Officer and one of our directors, |
Adopted 10b5-1 plan | Dec 10, 2024 | up to 624,285 | 512 days | 10-K Feb 21, 2025 |
What the company wroteOn December 10, 2024, Michael Xie, our Chief Technology Officer and one of our directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Michael Xie Plan”) during an open trading window in accordance with our insider trading policy. The Michael Xie Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Michael Xie Plan provides for the potential sale by Mr. Xie of up to (a) 624,285 shares of our common stock, issued upon the vesting and settlement of RSUs for shares of our common stock and the exercise of vested options to purchase shares of our common stock and (b) the net shares (which are not yet determinable) after shares are withheld to satisfy tax obligations upon such vesting and settlement of RSUs and PSUs, in each case, at the market price, all between March 11, 2025 and May 6, 2026. | |||||
| Ken Xie Chief Executive Officer and one of our directors |
Adopted 10b5-1 plan | Dec 9, 2024 | up to 734,880 | 513 days | 10-K Feb 21, 2025 |
What the company wroteOn December 9, 2024, Ken Xie, our Chief Executive Officer and one of our directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Ken Xie Plan”) during an open trading window in accordance with our insider trading policy. The Ken Xie Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Ken Xie Plan provides for the potential sale by Mr. Xie of up to (a) 734,880 shares of our common stock, issued upon the vesting and settlement of RSUs and PSUs for shares of our common stock and the exercise of vested options to purchase shares of our common stock and (b) the net shares (which are not yet determinable) after shares are withheld to satisfy tax obligations upon such vesting and settlement of RSUs and PSUs, in each case, at the market price, all between March 10, 2025 and May 6, 2026. | |||||
| Kenneth A. Goldman directors |
Adopted 10b5-1 plan | Dec 9, 2024 | up to 3,000 | 456 days | 10-K Feb 21, 2025 |
What the company wroteOn December 9, 2024, Kenneth A. Goldman, one of our directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Goldman Plan”) during an open trading window in accordance with our insider trading policy. The Goldman Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Goldman Plan provides for the potential sale by Mr. Goldman of up to 3,000 shares of our common stock, issued upon the exercise of vested options to purchase shares of our common stock, at the market price, so long as the market price is equal to or greater than $95.00 per share, between March 10, 2025 and March 10, 2026. | |||||
| William H. Neukom directors |
Adopted 10b5-1 plan | Dec 9, 2024 | not stated | 452 days | 10-K Feb 21, 2025 |
What the company wroteOn December 9, 2024, William H. Neukom, one of our directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the purchase of shares of our common stock (the “Neukom Plan”) during an open trading window in accordance with our insider trading policy. The Neukom Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Neukom Plan provides for the potential purchase by Mr. Neukom of up to $35,000 worth of shares of our common stock per at the market price, on five dates between March 6, 2025 and March 6, 2026, as specified in the Neukom Plan. | |||||
| John Whittle Chief Operating Officer |
Adopted 10b5-1 plan | May 22, 2024 | up to 141,820 | 548 days | 10-Q Aug 8, 2024 |
What the company wroteOn May 22, 2024, John Whittle, our Chief Operating Officer, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of our common stock (the “Whittle Plan”) during an open trading window in accordance with our insider trading policy. The Whittle Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Whittle Plan provides for the potential sale by Mr. Whittle of up to 141,820 shares of our common stock, issued upon the exercise of vested options to purchase shares of our common stock, at the market price, between August 21, 2024 and February 20, 2026. The Whittle Plan includes a representation from Mr. Whittle to the broker administering the plan that he was not in possession of any material nonpublic information regarding us or the securities subject to the Whittle Plan at the time that he entered into the Whittle Plan. He made a similar representation to us in connection with the adoption of the Whittle Plan under our insider trading policy. The representation was made as of May 22, 2024 and speaks only as of that date. In making the representation, Mr. Whittle did not provide assurance with respect to any material nonpublic information of which he was unaware, or with respect to any material nonpublic information acquired by him or us after the date of the representation. Once executed, transactions under the Whittle Plan will be disclosed publicly through Form 4 and/or Form 144 filings with the SEC in accordance with applicable securities laws, rules and regulations. Except as may be required by law, we do not undertake any obligation to update or report any modification, termination or other activity under current or future Rule 10b5-1 plans that may be adopted by Mr. Whittle or our other officers or directors or their affiliated entities. | |||||
| Keith Jensen Chief Financial Officer |
Adopted 10b5-1 plan | Mar 6, 2024 | up to 163,170 | 367 days | 10-Q May 6, 2024 |
| Judith Sim director |
Adopted 10b5-1 plan | Dec 6, 2023 | up to 20,637 | 367 days | 10-K Feb 26, 2024 |
| Patrice Perche Chief Revenue Officer and Executive Vice President of Support |
Adopted 10b5-1 plan | Nov 13, 2023 | up to 141,981 | 454 days | 10-K Feb 26, 2024 |
| Ken Xie officers and director |
Adopted plan | – | up to 150,000 | 434 days | 10-Q Nov 7, 2023 |
| Michael Xie officers and director |
Adopted plan | – | up to 100,000 | 434 days | 10-Q Nov 7, 2023 |
| Michael Xie and Ken Xie | Adopted plan | – | up to 50,000 | 434 days | 10-Q Nov 7, 2023 |
Show the other 12 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 8, 2023.
Form 144
Notices of planned sales
| Filed | Seller | Shares | Value | Shares came from | 10b5-1 plan | Form 4 sales after |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | KEN XIE Director, Officer |
161,483 | $22.0M | Exercise of Stock Options; Restricted Stock Units | adopted Mar 3, 2026 | 161,483 shares from Nov 2, 2026 |
| Nov 2, 2026 | MICHAEL XIE Director, Officer |
3,121 | $425K | Restricted Stock Units | adopted Mar 4, 2026 | 3,121 shares from Nov 2, 2026 |
| Sep 24, 2026 | Margrit Christiane Ohlgart Officer |
48 | $9K | Restricted Stock Units | adopted Jun 10, 2026 | 48 shares from Sep 24, 2026 |
| Sep 14, 2026 | JOHN WHITTLE Officer |
56,700 | $8.8M | Exercise of Stock Options | adopted Jun 5, 2026 | 56,700 shares from Sep 14, 2026 |
| Aug 4, 2026 | Margrit Christiane Ohlgart Officer |
387 | $63K | Restricted Stock Units | adopted Mar 7, 2025 | 387 shares from Aug 4, 2026 |
| Aug 3, 2026 | KEN QING XIE Director, Officer |
161,482 | $26.2M | Exercise of Stock Options; Restricted Stock Units | adopted Mar 3, 2026 | 161,482 shares from Aug 3, 2026 |
| Aug 3, 2026 | MICHAEL XIE Director, Officer |
3,121 | $505K | Restricted Stock Units | adopted Mar 4, 2026 | 3,121 shares from Aug 3, 2026 |
| Jun 3, 2026 | MICHAEL XIE Director, Officer |
3,907 | $582K | Restricted Stock Units | adopted Mar 4, 2026 | 3,907 shares from Jun 3, 2026 |
| Jun 2, 2026 | KEN QING XIE Director, Officer |
160,632 | $23.6M | Exercise of Stock Options; Restricted Stock Units | adopted Mar 3, 2026 | 160,632 shares from Jun 2, 2026 |
| May 21, 2026 | JOHN WHITTLE Officer |
146,015 | $19.0M | Exercise of Stock Options | adopted Feb 19, 2026 | 146,015 shares from May 21, 2026 |
| May 20, 2026 | Margrit Christiane Ohlgart Officer |
238 | $30K | RSU/PSU | adopted Mar 7, 2025 | 238 shares from May 20, 2026 |
| May 14, 2026 | Margrit Christiane Ohlgart Officer |
756 | $89K | RSU/PSU | adopted Mar 7, 2025 | 994 shares from May 14, 2026 |
| May 11, 2026 | MARGRIT CHRISTIANE OHLGART Officer |
238 | $27K | RSU/PSU | adopted Mar 7, 2025 | 1,232 shares from May 11, 2026 |
| May 7, 2026 | MARGRIT CHRISTIANE OHLGART Officer |
756 | $68K | RSU/PSU | adopted Mar 7, 2025 | 1,988 shares from May 7, 2026 |
| May 5, 2026 | MARGRIT CHRISTIANE OHLGART Officer |
596 | $53K | Restricted Stock Units and Performance Stock Units | adopted Mar 7, 2025 | 2,584 shares from May 5, 2026 |
| May 4, 2026 | KEN QING XIE Director, Officer |
5,355 | $462K | Restricted Stock Units | adopted Dec 9, 2024 | 165,987 shares from May 4, 2026 |
| May 4, 2026 | MICHAEL XIE Director, Officer |
2,478 | $214K | Restricted Stock Units | adopted Dec 10, 2024 | 6,385 shares from May 4, 2026 |
| Feb 3, 2026 | MARGRIT CHRISTIANE OHLGART Officer |
507 | $41K | Restricted Stock Units and Performance Stock Units | adopted Mar 7, 2025 | none found |
| Feb 2, 2026 | KEN QING XIE Director, Officer |
175,737 | $14.3M | Exercise of Stock Options; Performance Stock Units; Restricted Stock Units | adopted Dec 9, 2024 | none found |
| Feb 2, 2026 | MICHAEL XIE Director, Officer |
343,106 | $27.9M | Exercise of Stock Options; Performance Stock Units; Restricted Stock Units | adopted Dec 10, 2024 | none found |
| Nov 4, 2025 | MARGRIT CHRISTIANE OHLGART Officer |
110 | $10K | Restricted Stock Units | adopted Mar 7, 2025 | none found |
| Nov 3, 2025 | MICHAEL XIE Director, Officer |
3,546 | $306K | Restricted Stock Units | adopted Dec 10, 2024 | none found |
| Nov 3, 2025 | KEN QING XIE Director, Officer |
158,485 | $13.7M | Exercise of Stock Options; Restricted Stock Units | adopted Dec 9, 2024 | none found |
Show the other 15 notices
From the Form 144 XML filed with the SEC, since Nov 3, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.